305 related articles for article (PubMed ID: 11563971)
1. Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy.
Wahab NA; Yevdokimova N; Weston BS; Roberts T; Li XJ; Brinkman H; Mason RM
Biochem J; 2001 Oct; 359(Pt 1):77-87. PubMed ID: 11563971
[TBL] [Abstract][Full Text] [Related]
2. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis.
Riser BL; Denichilo M; Cortes P; Baker C; Grondin JM; Yee J; Narins RG
J Am Soc Nephrol; 2000 Jan; 11(1):25-38. PubMed ID: 10616837
[TBL] [Abstract][Full Text] [Related]
3. Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli.
Wahab NA; Schaefer L; Weston BS; Yiannikouris O; Wright A; Babelova A; Schaefer R; Mason RM
Diabetologia; 2005 Dec; 48(12):2650-60. PubMed ID: 16270194
[TBL] [Abstract][Full Text] [Related]
4. Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells.
Murphy M; Godson C; Cannon S; Kato S; Mackenzie HS; Martin F; Brady HR
J Biol Chem; 1999 Feb; 274(9):5830-4. PubMed ID: 10026205
[TBL] [Abstract][Full Text] [Related]
5. Roles of connective tissue growth factor and prostanoids in early streptozotocin-induced diabetic rat kidney: the effect of aspirin treatment.
Makino H; Mukoyama M; Sugawara A; Mori K; Suganami T; Yahata K; Fujinaga Y; Yokoi H; Tanaka I; Nakao K
Clin Exp Nephrol; 2003 Mar; 7(1):33-40. PubMed ID: 14586741
[TBL] [Abstract][Full Text] [Related]
6. Role of connective growth factor in plasminogen activator inhibitor-1 and fibronectin expression induced by transforming growth factor beta1 in renal tubular cells.
Zhang C; Meng XF; Zhu ZH; Yang X; Deng AG
Chin Med J (Engl); 2004 Jul; 117(7):990-6. PubMed ID: 15265370
[TBL] [Abstract][Full Text] [Related]
7. Connective tissue growth factor and its regulation: a new element in diabetic glomerulosclerosis.
Riser BL; Cortes P
Ren Fail; 2001; 23(3-4):459-70. PubMed ID: 11499561
[TBL] [Abstract][Full Text] [Related]
8. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB
Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
[TBL] [Abstract][Full Text] [Related]
9. Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy.
Wang S; Denichilo M; Brubaker C; Hirschberg R
Kidney Int; 2001 Jul; 60(1):96-105. PubMed ID: 11422741
[TBL] [Abstract][Full Text] [Related]
10. Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice.
Roestenberg P; van Nieuwenhoven FA; Joles JA; Trischberger C; Martens PP; Oliver N; Aten J; Höppener JW; Goldschmeding R
Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1344-54. PubMed ID: 16380465
[TBL] [Abstract][Full Text] [Related]
11. Connective tissue growth factor mediates high glucose effects on matrix degradation through tissue inhibitor of matrix metalloproteinase type 1: implications for diabetic nephropathy.
McLennan SV; Wang XY; Moreno V; Yue DK; Twigg SM
Endocrinology; 2004 Dec; 145(12):5646-55. PubMed ID: 15345671
[TBL] [Abstract][Full Text] [Related]
12. Role of connective tissue growth factor in renal tubular epithelial-myofibroblast transdifferentiation and extracellular matrix accumulation in vitro.
Zhang C; Meng X; Zhu Z; Yang X; Deng A
Life Sci; 2004 Jun; 75(3):367-79. PubMed ID: 15135656
[TBL] [Abstract][Full Text] [Related]
13. Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine.
Twigg SM; Cao Z; MCLennan SV; Burns WC; Brammar G; Forbes JM; Cooper ME
Endocrinology; 2002 Dec; 143(12):4907-15. PubMed ID: 12446618
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms through which bradykinin promotes glomerular injury in diabetes.
Tan Y; Wang B; Keum JS; Jaffa AA
Am J Physiol Renal Physiol; 2005 Mar; 288(3):F483-92. PubMed ID: 15692059
[TBL] [Abstract][Full Text] [Related]
15. Role of connective tissue growth factor in extracellular matrix degradation in renal tubular epithelial cells.
Zhang C; Zhu Z; Liu J; Yang X; Fu L; Deng A
J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):44-7. PubMed ID: 17393107
[TBL] [Abstract][Full Text] [Related]
16. CTGF mediates TGF-beta-induced fibronectin matrix deposition by upregulating active alpha5beta1 integrin in human mesangial cells.
Weston BS; Wahab NA; Mason RM
J Am Soc Nephrol; 2003 Mar; 14(3):601-10. PubMed ID: 12595495
[TBL] [Abstract][Full Text] [Related]
17. CTGF inhibits BMP-7 signaling in diabetic nephropathy.
Nguyen TQ; Roestenberg P; van Nieuwenhoven FA; Bovenschen N; Li Z; Xu L; Oliver N; Aten J; Joles JA; Vial C; Brandan E; Lyons KM; Goldschmeding R
J Am Soc Nephrol; 2008 Nov; 19(11):2098-107. PubMed ID: 18632843
[TBL] [Abstract][Full Text] [Related]
18. Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes.
Guha M; Xu ZG; Tung D; Lanting L; Natarajan R
FASEB J; 2007 Oct; 21(12):3355-68. PubMed ID: 17554073
[TBL] [Abstract][Full Text] [Related]
19. Salutary effect of pigment epithelium-derived factor in diabetic nephropathy: evidence for antifibrogenic activities.
Wang JJ; Zhang SX; Mott R; Knapp RR; Cao W; Lau K; Ma JX
Diabetes; 2006 Jun; 55(6):1678-85. PubMed ID: 16731830
[TBL] [Abstract][Full Text] [Related]
20. Connective tissue growth factor modulates extracellular matrix production in human subconjunctival fibroblasts and their proliferation and migration in vitro.
Yamanaka O; Saika S; Ikeda K; Miyazaki K; Kitano A; Ohnishi Y
Jpn J Ophthalmol; 2008; 52(1):8-15. PubMed ID: 18369694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
